Strong Vision First in Region to Provide Treatment for Farsightedness
Thursday, September 05, 2002
Scott MacRae, M.D., professor of Ophthalmology and professor of Visual Science at the University of Rochester Medical Center, is the first in the region to offer conductive keratoplasty, an alternative to laser surgery for individuals who are farsighted.
For patients who suffer from farsightedness, also called hyperopia, conductive keratoplasty (CK) can provide the same results as laser surgery without creating a flap, as with LASIK, or removing corneal tissue like other refractive procedures. CK uses radiofrequency energy to reshape the cornea.
"This adds another excellent tool in the correction of farsightedness," says MacRae, medical director of Strong Vision Laser Vision Correction at the University of Rochester Eye Institute.
Conductive keratoplasty is safe and minimally invasive. Once MacRae has determined a patient is a candidate for the procedure, he uses unique computer technology developed at University of Rochester to map out the patient's cornea to measure its curvature.
The procedure itself takes about three minutes. A topical anesthesia in the form of eye drops is applied to the cornea, then MacRae uses a small probe, thinner than a strand of human hair, to release radiofrequency energy. The probe is applied to the cornea to shrink the tissue. This shrinkage steepens the cornea surface to reshape it and adjust its refractive characteristics, correcting the patient's farsightedness.
The basic criteria for CK candidates are:
- Age 40 or older
- No drastic changes in vision or eyeglass prescription within the past year ·
- No eye conditions such as glaucoma, severe dryness, keratoconus, herpes of the eye, aggressive keloid formation or corneal dystrophy ·
- No physical conditions such as diabetes, pregnancy or nursing, or vascular or autoimmune diseases.
For more information about conductive keratoplasty, please call Strong Vision at (585) 273-2020.